CoChat

Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease

Open access
Thanassoulis, George, Williams, Ken, Altobelli, Kathleen Kimler, Pencina, Michael J., Cannon, Christopher P., Sniderman, Allan D. · 2016 · Circulation
Cited by 85

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Background—: Current guidelines recommend statins in the primary prevention of cardiovascular disease on the basis of predicted cardiovascular risk without directly considering the expected benefits of statin therapy based on the available randomized, controlled trial evidence. Methods and Results—: We included 2134 participants representing 71.8 million American residents potentially eligible for statins in primary prevention from the National Health and Nutrition Examination Survey for the years 2005 to 2010. We compared statin eligibilities using 2 separate approaches: a 10-year risk-based approach (≥7.5% 10-year risk) and an individualized benefit approach (ie, based on predicted absolute risk reduction over 10 years [ARR 10 ] ≥2.3% from randomized, controlled trial data). A risk-based approach led to the eligibility of 15.0 million (95% confidence interval, 12.7–17.3 million) Americans, whereas a benefit-based approach identified 24.6 million (95% confidence interval, 21.0–28.1 million). The corresponding numbers needed to treat over 10 years were 21 (range, 9–44) and 25 (range, 9–44). The benefit-based approach identified 9.5 million lower-risk (<7.5% 10-year risk) Americans not currently eligible for statin treatment who had the same or greater expected benefit from statins (≥2.3% ARR 10 ) compared with higher-risk individuals. This lower-risk/acceptable-benefit group includes younger individuals (mean age, 55.2 versus 62.5 years; P <0.001 for benefit based versus risk based) with higher low-density lipoprotein cholesterol (140 versus133 mg/dL; P =0.01). Statin treatment in this group would be expected to prevent an additional 266 508 cardiovascular events over 10 years. Conclusions—: An individualized statin benefit approach can identify lower-risk individuals who have equal or greater expected benefit from statins in primary prevention compared with higher-risk individuals. This approach may help develop guideline recommendations that better identify individuals who meaningfully benefit from statin therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.115.018383

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 24

  1. 10.1056/NEJMoa1315665 · DOI · Paper page
  2. 10.1161/CIRCULATIONAHA.115.016846 · DOI · Paper page
  3. 10.1016/j.jacc.2015.07.066 · DOI · Paper page
  4. 10.1016/j.jacc.2014.12.028 · DOI
  5. 10.1001/jama.2013.276529 · DOI
  6. 10.1001/jama.2015.6822 · DOI · Paper page
  7. 10.1093/eurheartj/ehu004 · DOI · Paper page
  8. 10.1136/bmj.g3047 · DOI
  9. 10.1016/j.jacl.2014.08.004 · DOI
  10. 10.1093/eurheartj/ehv340 · DOI · Paper page
  11. 10.1001/jama.2015.3595 · DOI · Paper page
  12. 10.1093/clinchem/18.6.499 · DOI · Paper page
  13. 10.1056/NEJM199511163332001 · DOI · Paper page
  14. 10.1016/S0140-6736(03)12948-0 · DOI · Paper page
  15. Johnson CL, Paulose-Ram R, Ogden CL, Carroll MD, Kruszon-Moran D, Dohrmann SM, Curtin LR. National health and nutrition examination survey: analytic guidelines, 1999–2010. Vital Health Stat 2. 2013:1–24.
  16. 10.1371/journal.pone.0101717 · DOI · Paper page
  17. 10.1016/j.amjcard.2014.07.076 · DOI
  18. 10.1016/j.jacc.2009.12.057 · DOI
  19. 10.1016/j.jacc.2012.09.016 · DOI
  20. 10.1161/CIRCULATIONAHA.114.012477 · DOI · Paper page
  21. 10.1016/S0140-6736(14)61994-2 · DOI · Paper page
  22. 10.1016/S0140-6736(11)60784-8 · DOI · Paper page
  23. 10.1016/j.jacc.2015.02.025 · DOI · Paper page
  24. 10.1001/jama.2015.6177 · DOI

Cited by

See all 85

Metadata

Authors
Thanassoulis, G., Williams, K., Altobelli, K. K., Pencina, M. J., Cannon, C. P., & Sniderman, A. D.
Venue
Circulation
Published
2016-04-19
Volume
133
Issue
16
Pages
1574-1581
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2290361157
Cited by
85
References
15
FWCI
15.93
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.